Table 2.
Distributions of age and PSA at diagnosis for diagnosed men and cancer deaths.
Age at diagnosis |
|||||
---|---|---|---|---|---|
Overall | 50–59 | 60–69 | 70–79 | 80–89 | |
Number of men diagnosed with prostate cancer vs. PSA at diagnosis | |||||
PSA (ng/mL) | |||||
0–2.9 | 70,836 | 8,761 | 19,112 | 28,881 | 14,082 |
3–4.9 | 40,912 | 7,292 | 15,039 | 14,200 | 4,381 |
5–9.9 | 67,512 | 10,729 | 24,432 | 25,049 | 7,302 |
10–19.9 | 27,323 | 3,333 | 7,419 | 10,984 | 5,587 |
20–49.9 | 13,217 | 1,385 | 2,884 | 5,094 | 3,854 |
50–99.9 | 4,434 | 405 | 840 | 1,676 | 1,513 |
≥100 | 5,847 | 481 | 1,137 | 2,167 | 2,062 |
Total | 230,081 | 32,386 | 70,863 | 88,051 | 38,781 |
Number of men died of prostate cancer (% of diagnosed in category) | |||||
PSA (ng/mL) | |||||
0–2.9 | 4,467 (6) | 171 (2) | 629 (3) | 1,980 (7) | 1,687 (12) |
3–4.9 | 2,203 (5) | 112 (2) | 414 (3) | 1,023 (7) | 654 (15) |
5–9.9 | 3,301 (6) | 263 (2) | 855 (3) | 2,043 (8) | 1,140 (16) |
10–19.9 | 3,749 (14) | 181 (5) | 618 (8) | 1,710 (16) | 1,240 (22) |
20–49.9 | 3,553 (27) | 196 (14) | 545 (19) | 1,490 (29) | 1,322 (34) |
50–99.9 | 1,933 (44) | 128 (32) | 306 (36) | 805 (48) | 694 (46) |
≥100 | 3,936 (67) | 320 (67) | 724 (64) | 1,502 (69) | 1,390 (67) |
Total | 24,142 (10) | 1,371 (4) | 4,091 (6) | 10,553 (12) | 8,127 (21) |